browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
33b06a5a-e51c-4af0-a3f9-1ba708d1f9a7
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-21 15:50:08
Income (reported)
Expenses (reported)
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

MCALLISTER & QUINN, LLC

​Federal and Foundation Grants and Government Relations consulting firm.

Contact
ANDRE JACOBS
Phone
+1 202-296-2741
Address
zip:20006, city:Washington, state:DC, street:1625 Eye Street, NW Suite 750
Client

GLUCOTRACK, INC.

Medical technology innovator regarding diabetes

State
VA
Country
US
Effective date
2025-01-01
Issues lobbied + lobbyists (3)

DEF — Defense

Department of Defense Appropriations S. 2572 - Department of Defense Appropriations Act, 2026 - Provisions related to Glucotrackss appropriations requests. No bill number - Department of Defense Appropriations Act, 2027 - Provisions related to Glucotracks appropriations requests.

Lobbyists:

Government entities lobbied: SENATE

HCR — Health Issues

Department of Defense Appropriations S. 2572 - Department of Defense Appropriations Act, 2026 - Provisions related to Glucotrackss appropriations requests. No bill number - Department of Defense Appropriations Act, 2027 - Provisions related to Glucotracks appropriations requests.

Lobbyists:

Government entities lobbied: SENATE

BUD — Budget/Appropriations

Department of Defense Appropriations S. 2572 - Department of Defense Appropriations Act, 2026 - Provisions related to Glucotrackss appropriations requests. No bill number - Department of Defense Appropriations Act, 2027 - Provisions related to Glucotracks appropriations requests.

Lobbyists:

Government entities lobbied: SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.